Institutional investors purchased a net $57.1 thousand shares of ACER during the quarter ended December 2017 and now own 8.16% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NANTAHALA CAPITAL MANAGEMENT LLC Bought 250.3 Thousand shares of Acer Therapeutics Inc
HEARTLAND ADVISORS, INC. Bought 55.6 Thousand shares of Acer Therapeutics Inc
MARSHALL WACE NORTH AMERICA LP Bought 20.1 Thousand shares of Acer Therapeutics Inc